141 related articles for article (PubMed ID: 17129966)
21. Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
Lagos R; Munoz A; Dumas R; Pichon S; Zambrano B; Levine M; Vidor E
Vaccine; 2003 Sep; 21(25-26):3730-3. PubMed ID: 12922104
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
[TBL] [Abstract][Full Text] [Related]
23. [A comparative study on safety and immunogenicity of an inactivated hepatitis A vaccine in HBsAg carriers and healthy children].
Chen J; Ren Y; Wu W; Ma S; Li S; Wang J; Kang W; Han L; Gao S; Zhang Y; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):380-1. PubMed ID: 12665912
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
D'Acremont V; Herzog C; Genton B
J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
[TBL] [Abstract][Full Text] [Related]
25. [Safety and immunogenicity of a new inactivated hepatitis A vaccine].
Ren A; Ma J; Feng F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):357-9. PubMed ID: 11986726
[TBL] [Abstract][Full Text] [Related]
26. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
27. [Studies on vaccination schedule of inactivated hepatitis A vaccine].
Hu Y; Tan S; Jin W
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):618-20. PubMed ID: 11798830
[TBL] [Abstract][Full Text] [Related]
28. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence.
Van Herck K; Van Damme P
J Med Virol; 2001 Jan; 63(1):1-7. PubMed ID: 11130881
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and reactogenicity of an inactivated hepatitis A vaccine in Indian adults.
Das K; Jain A; Gupta RK; Kar P
Natl Med J India; 1999; 12(6):268-9. PubMed ID: 10732428
[TBL] [Abstract][Full Text] [Related]
30. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
31. Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine.
Van Herck K; Crasta PD; Messier M; Hardt K; Van Damme P
Hum Vaccin Immunother; 2012 Mar; 8(3):323-7. PubMed ID: 22327499
[TBL] [Abstract][Full Text] [Related]
32. [Immunogenicity and safety of three consecutive lots on an inactivated hepatitis A vaccine: a double-blind, immunogenicity and safety of three consecutive lots on a inactivated hepatitis A vaccine:a double-blind, randomized and controlled trial in children].
Jiang WP; Wang YL; Chen WY; Xu WG; Chen JT; Wang X; Liu Y; Yin WD
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):556-9. PubMed ID: 19040036
[TBL] [Abstract][Full Text] [Related]
33. Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response.
Mayorga O; Bühler S; Jaeger VK; Bally S; Hatz C; Frösner G; Protzer U; Van Damme P; Egger M; Herzog C
J Infect Dis; 2016 Nov; 214(10):1498-1506. PubMed ID: 27601623
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).
Vidor E; Ratheau C; Briantais P; Vuillier D
J Travel Med; 1998 Dec; 5(4):167-72. PubMed ID: 9876189
[TBL] [Abstract][Full Text] [Related]
35. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants.
Letson GW; Shapiro CN; Kuehn D; Gardea C; Welty TK; Krause DS; Lambert SB; Margolis HS
J Pediatr; 2004 Mar; 144(3):327-32. PubMed ID: 15001936
[TBL] [Abstract][Full Text] [Related]
36. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years.
Van Der Wielen M; Vertruyen A; Froesner G; Ibáñez R; Hunt M; Herzog C; Van Damme P
Pediatr Infect Dis J; 2007 Aug; 26(8):705-10. PubMed ID: 17848882
[TBL] [Abstract][Full Text] [Related]
38. Vaccination of newborns against hepatitis A in the presence of maternally derived antibodies.
Vidor E
J Comp Pathol; 2007 Jul; 137 Suppl 1():S42-5. PubMed ID: 17555761
[TBL] [Abstract][Full Text] [Related]
39. Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu.
Wang H; Chen X; Chen Z; Lu W; Poerschke G; Eves K; Gress J; Kuter B
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):949-53. PubMed ID: 15916096
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis A vaccines and the elderly.
Genton B; D'Acremont V; Furrer HJ; Hatz C; Louis Loutan
Travel Med Infect Dis; 2006 Dec; 4(6):303-12. PubMed ID: 17098625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
